Recon: FDA approves Ozempic to reduce kidney disease progression; CDC ordered to immediately halt work with WHO

ReconReconApproval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)